Background. Allografts from older liver donors (OLDs), 70 years or older are often discarded for fear of inferior outcomes. We previously identified "preferred recipients" who did not suffer the higher risk of graft loss and mortality associated with OLDs. Preferred recipients were first-time, non-status 1 registrants older than 45 years, body mass index less than 35, indication other than hepatitis C, and cold ischemia time less than 8 hours. Methods. We assessed the validity of the preferred recipient construct in a larger, more recent cohort (38891 patients, 2006-2013). We compared recipients of OLD grafts to recipients of average liver donors (ALDs, age = 40-69) and ideal liver donors (ILDs, age = 18-39) grafts using multilevel Cox regression adjusting for recipient and transplant factors. Results. The use of OLD grafts in preferred recipients has increased from 2006 to 2013 (P = 0.02). Preferred recipients Model for End-Stage Liver Disease scores ranged 6 to 40. Preferred recipients had similar 5-year all-cause graft loss (ACGL) with OLD versus ALD and ILD grafts (25.4% vs 24.5% and 21.6%). Conversely, nonpreferred recipients had higher 5-year ACGL with OLD versus ALD and ILD grafts (41.4% vs 32.9% and 25.6%). After adjustment, preferred recipients had similar graft loss with OLD versus ALD grafts (hazard ratio [HR], 0.92 1.08 1.27 ; P = 0.3) and ILD grafts (HR, 0.98 1.16 1.39 , P = 0.09); however, nonpreferred recipients had higher ACGL risk with OLD grafts versus ALD (HR, 1.28 1.41 1.56 , P < 0.001) and ILD grafts (HR, 1.50 1.67 1.86 , P < 0.001). Similar trends are seen with mortality. Conclusions. Because preferred recipients comprise 43.3% (n = 2916) of the current waitlist and span the full range of Model for End-Stage Liver Disease scores, transplanted OLD allografts could be distributed without added risk of graft loss or mortality.
O ver 14000 patients are currently on the liver transplantation (LT) waitlist, and each year, over 10% of these registrants will die without a transplant. 1 One potential expansion of the donor pool is to increase use of higher-risk organs, such as those from donors older than 70 years. [2] [3] [4] [5] Historically, increased rates of post-LT mortality and graft loss reported with older liver donor (OLD) allografts caused a reluctance to use these organs. [6] [7] [8] [9] [10] This is reflected in the substantial variation in OLD use across transplant centers (0-33% of transplanted grafts) 11 and United Network of Organ Sharing region (0.9-12.9% of transplanted grafts). 12 Based on data from 2002 to 2005, we previously identified a group of "preferred recipients" for OLDs who do not incur additional risk of graft failure or death. 13 Our study identified preferred recipients as first-time, non-status 1 registrants older than 45 years, body mass index (BMI) less than 35, an indication for transplantation other than hepatitis C virus (HCV), and receipt of an organ with cold ischemia time (CIT) less than 8 hours. 13 Recipients with these characteristics had the same outcomes with OLDs as they might have had with younger donors, that is, these characteristics attenuated the impact of OLDs. However, much has changed in allocation (eg, hepatocellular carcinoma exception points), donor/recipient matching (increasing age of LT recipients 14 and donors, 15, 16 changes in indication for LT 14 )
, and treatment for HCV with direct-acting antivirals in the past decade. It is unclear whether this paradigm still identifies preferred recipients for OLD allografts. Furthermore, it is unknown whether general practice has improved recipient selection for OLD allografts.
To inform clinical practice, we assessed the validity of the preferred recipient construct using national registry data for deceased donor liver transplantation(DDLTs) performed from 2006 to 2013, comparing posttransplant survival by donor age for preferred and nonpreferred recipients. Additionally, we aimed to characterize trends in OLD allograft transplantation in preferred and nonpreferred recipients.
MATERIALS AND METHODS

Data Source
This study used data from the Scientific Registry of Transplant Recipients (SRTR) external release made available in September 2017. The SRTR data system includes data on all donors, waitlisted candidates, and transplant recipients in the United States (US), submitted by members of the Organ Procurement and Transplantation Network (OPTN), and has been previously described. 17 The Health Resources and Services Administration, US Department of Health and Human Services, provides oversight to the activities of the OPTN and SRTR contactors.
Study Population
We identified 38891 adult (age ≥ 18), liver-only DDLT between January 1, 2006, and December 31, 2013, to examine trends in use of OLDs and test the preferred recipient construct.
Exposure
The primary exposure of interest was donor age category. Donors were categorized as ideal liver donors (ILDs) ages 18 to 39 years, average liver donors (ALDs) ages 40 to 69 years, and older liver donors (OLDs) 70 years or older.
Outcome
The primary outcomes of interest were mortality and allcause graft loss (ACGL). In SRTR, mortality is ascertained by transplant center report and a linkage with the Social Security Death Master File. All-cause graft loss incorporates mortality, graft loss, and retransplant events. Graft loss and retransplant events are ascertained by transplant center report.
Definition of Preferred Recipients
Preferred recipients were defined as initially described based on DDLTs from 2002 to 2005: first-time, non-status 1 registrants older than 45 years, BMI less than 35, indication for LT other than HCV, and receipt of an organ with CIT less than 8 hours. 13 There were no restrictions placed on Model for End-Stage Liver Disease (MELD) scores. This definition was originally built by testing for strong effect modifiers (statistical interaction) of the donor age in unadjusted Cox regression models (a priori hazard ratio threshold of 1.20). After identifying strong effect modifiers, the joint construct was assessed using the Kaplan-Meier method and Cox regression. 13 
Statistical Analysis
Preferred and nonpreferred recipient transplant characteristics were compared with the Mann-Whitney rank-sum test (continuous variables) or χ 2 test (categorical variables). Cuzick test of trend was used to quantify trends in OLD recipients over time in preferred and nonpreferred recipients. Differences in unadjusted mortality and ACGL were assessed using the log-rank test of equality. The hazard of mortality and ACGL were estimated using the Kaplan-Meier method and Cox proportional hazards regression adjusting for recipient (continuous age, sex, African American race, MELD at transplant, life support at transplant, diabetes, history of previous abdominal surgery, history of portal vein thrombosis) and transplant factors (transplant year); stratified, separate models were used to measure the association of donor age (OLD vs ILD and ALD) and preferred candidate status. Martingale residuals were used to inform the functional form for continuous variables, such as MELD score at transplant. Based on the nonlinear relationship between the Martingale residuals and MELD, MELD score was categorized as follows: 6 to 15, 16 to 25, 26 to 34, and 35 to 40 including status 1. To account for center-level clustering and variation, we used shared frailties Cox regression, which is similar to multilevel regression. Transplant recipients were followed up for up to 5 years (fixed type I censoring) or March 31, 2017, whichever came first. We used a 2-sided α of 0.05 to indicate a statistically significant difference. When applicable, 95% confidence intervals are reported as per the method of Louis and Zeger. 18 All analyses were performed using Stata 15/MP for Linux (College Station, TX).
RESULTS
Study Population
The study population consisted of 38891 DDLT recipients (2006-2013) including 1861 (4.8%) OLD recipients. There were 252 OLD grafts 80 years or older and 5 aged 90 years or older. Older liver donors were more likely to be female, diabetic, hypertensive, and have a lower BMI and less likely to be African American or Hispanic than donors younger than 70 years (all P < 0.001). Older liver donors were more likely to have cerebrovascular accident as the cause of death and be nationally shared (both P < 0.001) ( Table 1) .
Older liver donor graft recipients were older (P < 0.001) and more likely to be female (P < 0.001), diabetic (P < 0.001), and hypertensive (P = 0.02). Furthermore, OLD graft recipients had lower calculated MELD scores (P < 0.001) and were less likely be African American (P < 0.001), on life support (P < 0.001), a previous transplant recipient (P < 0.001), and have HCVas a primary indication for LT (P < 0.001) ( Table 2) 
Validation of Preferred Recipients: ACGL
One-year ACGL for preferred recipients with OLD, ALD, and ILD grafts were 12.3%, 11.6%, and 10.0%, respectively. Three-year ACGL were 19.1%, 19.2%, and 16.2%, and 5-year ACGL were 25.4%, 24.5%, and 21.6% for preferred recipients of OLD, ALD, and ILD grafts, respectively. After adjustment, preferred recipients had similar graft loss with OLD versus ALD grafts (hazard ratio [HR], 0.92 1.08 1.27 , P = 0.3) and ILD grafts ( 0.98 1.16 1.39 , P = 0.09) ( Table 3) .
One-year ACGL for nonpreferred recipients with OLD, ALD, and ILD grafts were 22.5%, 16.2%, and 12.6%, respectively. Three-year ACGL were 33.4%, 26.2%, and 20.3%, and 5-year ACGL were 41.4%, 32.9%, and 25.6% for nonpreferred recipients of OLD, ALD, and ILD grafts, respectively ( Figure 3 ). After adjustment, nonpreferred recipients had higher ACGL risk with OLD grafts versus ALD (adjusted HR [aHR], 1.28 1.41 1.56 , P < 0.001) and ILD grafts ( 1.50 1.67 1.86 , P < 0.001) ( Table 3) .
Validation of Preferred Recipients: Mortality
One-year mortality for preferred recipients with OLD, ALD, and ILD grafts was 9.4%, 9.3%, and 8.9%, respectively. Three-year mortality was 16.5%, 16.7%, and 15.1%, and 5-year mortality was 22.6%, 22.0%, and 20.4% for preferred recipients of OLD, ALD, and ILD grafts, respectively ( Figure 4) . In an adjusted model, preferred recipients had similar mortality risk with OLD versus ALD grafts (HR, 0.87 1.03 1.20 ; P = 0.8) and ILD grafts (HR, 0.88 1.07 1.29 ; P = 0.5) ( Table 3) .
One-year mortality for nonpreferred recipients with OLD, ALD, and ILD grafts was 18.0%, 13.3%, and 10.7%, The distribution of MELD scores were statistically different, with a greater proportion of high MELD scores among nonpreferred recipients compared to preferred recipients (P < 0.001). The 90th percentile of MELD was 37 for preferred candidates, whereas the 90th-percentile of MELD was 39 for nonpreferred candidates. respectively. Three-year mortality was 28.8%, 22.9%, and 18.0%, and 5-year mortality was 36.2%, 29.4%, and 23.2% for nonpreferred recipients of OLD, ALD, and ILD grafts, respectively ( Figure 4) . In an adjusted model, nonpreferred recipients had higher mortality risk with OLD versus ALD (aHR, 1.18 1.31 1.46 ; P < 0.001) and ILD grafts (aHR, 1.36 1.53 1.72 ; P < 0.001) ( Table 3) .
DISCUSSION
In this nationwide study of 38891 DDLTs, we validated our previous preferred recipient model in a larger, modern cohort. Preferred recipients MELD scores ranged from 6 to 40. After adjustment, preferred recipients had no difference in ACGL comparing donors 70 years or older with 40 to 69 years (P = 0.3) or younger than 40 years (P = 0.09). However, nonpreferred recipients had a 41% higher risk (P < 0.001) of ACGL with a donor 70 years or older versus 40 to 69 years and a 67% higher risk (P < 0.001) versus younger than 40. Results were similar for mortality. Preferred recipients account for 43.3% of the active liver waitlist and have MELD scores range from 6 to 40. Since 2006, the use of OLD grafts in preferred recipients has increased, whereas the use of OLD grafts in nonpreferred recipients has decreased. That said, in 2013, 40.9% of OLD grafts were used in nonpreferred candidates despite the presence of ample preferred candidates on the active waitlist.
It is well known that donor, recipient, and transplant characteristics impact graft and patient survival. 8, 19 Previous studies have shown higher rates of graft failure and mortality with OLD grafts, but these studies did not investigate recipient subgroups who may fare better or worse with OLD grafts. [6] [7] [8] [9] Our results confirmed that some recipients experienced inferior outcomes with OLD use; however, our study also identifies and validates a group of preferred recipients who did not incur additional risk of graft loss or mortality with OLD grafts. Nonpreferred recipients suffer adverse effects (graft loss and mortality) from OLDs that preferred recipients do not.
Several studies in the era of MELD-based allocation have reported equivalent outcomes between older donor and younger donor DDLT in select recipients. [20] [21] [22] [23] [24] [25] [26] These studies identified recipient and transplant characteristics, such as high MELD, older age, HCV infection, and longer CIT as risk factors for poor outcomes with OLD grafts, but equivalent outcomes between OLD and younger donors otherwise. However, the generalizability of these studies is limited by: small sample sizes, single-center, non-US study populations, exclusion of HCV-infected recipients and certain donor age groups. [20] [21] [22] [23] [24] [25] [26] [27] Additionally, these studies failed to formally test or define the population of recipients in which the risks Preferred recipients were first-time LT recipients, non-status 1 registrants with age >45, BMI <35, indication for LT other than hepatitis C and CIT <8 hours. Models were adjusted for recipient age, sex, MELD at transplant, life support at time of transplant, history of previous abdominal surgery, history of portal vein thrombosis, and transplant year.
associated with OLD grafts were mitigated. 12, [20] [21] [22] [23] [24] [25] [26] [27] Our study includes a larger cohort and represents the MELD era DDLT population in the United States between 2006 and 2013, including all non-status 1 adult donors and recipients. Importantly, we identify a preferred candidate for OLD grafts incorporating recipient and transplant characteristics, irrespective of registrant MELD score or donor organ characteristics other than age.
Older liver donor grafts do not carry additional risk of graft loss and mortality to preferred recipients, even after adjustment for recipient, donor, and transplant factors. Matching OLDs to preferred recipients can expand the donor pool without increasing donor age-associated graft loss or mortality.
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